304 related articles for article (PubMed ID: 32360846)
1. The rapid adoption of opportunistic salpingectomy at the time of hysterectomy for benign gynecologic disease in the United States.
Mandelbaum RS; Adams CL; Yoshihara K; Nusbaum DJ; Matsuzaki S; Matsushima K; Klar M; Paulson RJ; Roman LD; Wright JD; Matsuo K
Am J Obstet Gynecol; 2020 Nov; 223(5):721.e1-721.e18. PubMed ID: 32360846
[TBL] [Abstract][Full Text] [Related]
2. The impact of opportunistic salpingectomy on ovarian cancer mortality and healthcare costs: a call for universal insurance coverage.
Naumann RW; Hughes BN; Brown J; Drury LK; Herzog TJ
Am J Obstet Gynecol; 2021 Oct; 225(4):397.e1-397.e6. PubMed ID: 33798477
[TBL] [Abstract][Full Text] [Related]
3. Paradigm shift from tubal ligation to opportunistic salpingectomy at cesarean delivery in the United States.
Mandelbaum RS; Matsuzaki S; Sangara RN; Klar M; Matsushima K; Roman LD; Paulson RJ; Wright JD; Matsuo K
Am J Obstet Gynecol; 2021 Oct; 225(4):399.e1-399.e32. PubMed ID: 34181896
[TBL] [Abstract][Full Text] [Related]
4. Racial and ethnic differences in the adoption of opportunistic salpingectomy for ovarian cancer prevention in the United States.
Karia PS; Huang Y; Tehranifar P; Visvanathan K; Wright JD; Genkinger JM
Am J Obstet Gynecol; 2022 Aug; 227(2):257.e1-257.e22. PubMed ID: 35489439
[TBL] [Abstract][Full Text] [Related]
5. The performance and safety of bilateral salpingectomy for ovarian cancer prevention in the United States.
Hanley GE; McAlpine JN; Pearce CL; Miller D
Am J Obstet Gynecol; 2017 Mar; 216(3):270.e1-270.e9. PubMed ID: 27810554
[TBL] [Abstract][Full Text] [Related]
6. Extending the safety evidence for opportunistic salpingectomy in prevention of ovarian cancer: a cohort study from British Columbia, Canada.
Hanley GE; Kwon JS; Finlayson SJ; Huntsman DG; Miller D; McAlpine JN
Am J Obstet Gynecol; 2018 Aug; 219(2):172.e1-172.e8. PubMed ID: 29852159
[TBL] [Abstract][Full Text] [Related]
7. No. 344-Opportunistic Salpingectomy and Other Methods of Risk Reduction for Ovarian/Fallopian Tube/Peritoneal Cancer in the General Population.
Salvador S; Scott S; Francis JA; Agrawal A; Giede C
J Obstet Gynaecol Can; 2017 Jun; 39(6):480-493. PubMed ID: 28527613
[TBL] [Abstract][Full Text] [Related]
8. Examining indicators of early menopause following opportunistic salpingectomy: a cohort study from British Columbia, Canada.
Hanley GE; Kwon JS; McAlpine JN; Huntsman DG; Finlayson SJ; Miller D
Am J Obstet Gynecol; 2020 Aug; 223(2):221.e1-221.e11. PubMed ID: 32067967
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of opportunistic salpingectomy for ovarian cancer prevention.
Dilley SE; Havrilesky LJ; Bakkum-Gamez J; Cohn DE; Michael Straughn J; Caughey AB; Rodriguez MI
Gynecol Oncol; 2017 Aug; 146(2):373-379. PubMed ID: 28577884
[TBL] [Abstract][Full Text] [Related]
10. Uptake and Predictors of Opportunistic Salpingectomy for Ovarian Cancer Risk Reduction in the United States.
Karia PS; Joshu CE; Visvanathan K
Cancer Prev Res (Phila); 2021 Dec; 14(12):1101-1110. PubMed ID: 34413116
[TBL] [Abstract][Full Text] [Related]
11. ACOG Committee Opinion No. 774: Opportunistic Salpingectomy as a Strategy for Epithelial Ovarian Cancer Prevention.
Obstet Gynecol; 2019 Apr; 133(4):e279-e284. PubMed ID: 30913199
[TBL] [Abstract][Full Text] [Related]
12. Opportunistic bilateral salpingectomy during gynaecological surgery for benign disease: A survey of current Australian practice.
Kapurubandara S; Qin V; Gurram D; Anpalagan A; Merkur H; Hogg R; Brand A
Aust N Z J Obstet Gynaecol; 2015 Dec; 55(6):606-11. PubMed ID: 26768958
[TBL] [Abstract][Full Text] [Related]
13. Hospital Variation in the Practice of Bilateral Salpingectomy With Ovarian Conservation in 2012.
Xu X; Desai VB
Obstet Gynecol; 2016 Feb; 127(2):297-305. PubMed ID: 26942357
[TBL] [Abstract][Full Text] [Related]
14. National trends of adnexal surgeries at the time of hysterectomy for benign indication, United States, 1998-2011.
Mikhail E; Salemi JL; Mogos MF; Hart S; Salihu HM; Imudia AN
Am J Obstet Gynecol; 2015 Nov; 213(5):713.e1-13. PubMed ID: 25935772
[TBL] [Abstract][Full Text] [Related]
15. The Use of Opportunistic Salpingectomy at the Time of Benign Hysterectomy.
Till SR; Kobernik EK; Kamdar NS; Edwards MG; As-Sanie S; Campbell DA; Morgan DM
J Minim Invasive Gynecol; 2018 Jan; 25(1):53-61. PubMed ID: 28712794
[TBL] [Abstract][Full Text] [Related]
16. ACOG Committee Opinion No. 774 Summary: Opportunistic Salpingectomy as a Strategy for Epithelial Ovarian Cancer Prevention.
Obstet Gynecol; 2019 Apr; 133(4):842-843. PubMed ID: 30913193
[TBL] [Abstract][Full Text] [Related]
17. The Evolution of and Evidence for Opportunistic Salpingectomy.
Dilley SE; Straughn JM; Leath CA
Obstet Gynecol; 2017 Oct; 130(4):814-824. PubMed ID: 28885426
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of salpingectomy at hysterectomy to reduce the risk of epithelial ovarian cancer: a systematic review.
Darelius A; Lycke M; Kindblom JM; Kristjansdottir B; Sundfeldt K; Strandell A
BJOG; 2017 May; 124(6):880-889. PubMed ID: 28190289
[TBL] [Abstract][Full Text] [Related]
19. Hysterectomy with opportunistic salpingectomy versus hysterectomy alone.
van Lieshout LAM; Steenbeek MP; De Hullu JA; Vos MC; Houterman S; Wilkinson J; Piek JM
Cochrane Database Syst Rev; 2019 Aug; 8(8):CD012858. PubMed ID: 31456223
[TBL] [Abstract][Full Text] [Related]
20. Prophylactic salpingectomy for the prevention of ovarian cancer: Who should we target?
Kotsopoulos J; Narod SA
Int J Cancer; 2020 Sep; 147(5):1245-1251. PubMed ID: 32037528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
